RT Journal Article
SR Electronic
T1 Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2<sup>+</sup> pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002267
DO 10.1136/jitc-2020-002267
VO 9
IS 7
A1 Chu, Yaya
A1 Nayyar, Gaurav
A1 Jiang, Susiyan
A1 Rosenblum, Jeremy M.
A1 Soon-Shiong, Patrick
A1 Safrit, Jeffrey T
A1 Lee, Dean A.
A1 Cairo, Mitchell S.
YR 2021
UL http://jitc.bmj.com/content/9/7/e002267.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.